期刊文献+

髓母细胞瘤术后骨转移二例报告并文献复习 被引量:1

原文传递
导出
摘要 1病例报告 病例1,患者女,27岁。2005年或头晕、恶心和呕吐1个月,发现小脑占位病变,考虑髓母细胞瘤。于2005-10初入我院神经外科,于2005—10—25行颅后窝开颅小脑髓母细胞瘸切除术、脑室腹腔分流术,手术后症状好转,术后病理示髓母细胞瘤(图1A)。术后行头部伽玛刀治疗。
出处 《中华肿瘤防治杂志》 CAS 北大核心 2012年第9期710-711,共2页 Chinese Journal of Cancer Prevention and Treatment
  • 相关文献

参考文献11

  • 1魏微,张微微,黄勇华.貌似颈椎病的小脑髓母细胞瘤(附一例报告)[J].临床误诊误治,2009,22(4):41-42. 被引量:2
  • 2Spreafico F, Massimino M, Gandola L, et al. Survival of adults treated for medulloblastoma using pediatric protocols[J]. Eur J Cancer, 2005,41 (2) 1304-1310.
  • 3Arnold CP. Long-term survival in a child with extraneural metas- tasis from medulloblastoma treated with chemo-radiotherapy[J]. Med Pediatr Oncol, 2003,40(6) : 396-397.
  • 4Kim W,Choy W,Dye ],et al. The tumor biology and molecular characteristics of medulloblastoma identifying prognostic factors associated with survival outcomes and prognosis~J~. J Clinical Neurosci, 2011,18(7) : 886-890.
  • 5Mazloom A,Zangeneh AH,Bulino AC,et al. Prognostic Factors After Extraneural Metastasis of Medulloblastoma[-J~. Int J Radi Oncol,2010,78(1) ~72~78.
  • 6Abasioglu U, Vzel O, Sengoz M, et al. Medulloblastoma in a- dults~treatment results and prognostic factors[J]. Radiat Oncol Biol Phys, 2002,54 (3) 855-860.
  • 7张静,申良方,涂青松.40例髓母细胞瘤综合治疗分析[J].中国医学工程,2006,14(3):283-285. 被引量:3
  • 8Bourdeaat F, Miquel C, Alapetite C, et al. Medulloblatomas: up- date on a heterogeneous disease[J]. Curr Opin Oncol, 2011,23 (6) :630-637.
  • 9Rieken S,Gaiser T,Mohr A,et al. Outcome and prognostic factors of desmoplastic medulloblastoma treated within a multidisciplinary treatment concept~J]. BMC Cancer,2010,10(10) :450.
  • 10Antonio R,Daniela R,Giorgio A,et al. Phase I study of temo- zolomide combined with oral etoposide in children with recurrent or progressive medulloblastoraa[J]. Eur J Cancer,2010,46(16) : 2943-2999.

二级参考文献8

  • 1舒凯,雷霆,李龄.髓母细胞瘤诊断与治疗研究[J].中华神经外科疾病研究杂志,2005,4(4):382-384. 被引量:12
  • 2Smee R I, Williams J R. Medulloblastomas-primitive neuroectodermal tumours in the adult population[ J ]. J Med Imaging Radiat Oncol,2008,52( 1 ) :72-76.
  • 3Ang C, HauerstockD, Guiot M C, et al. Characteristics and outcomes of medulloblastoma in adults. Pediatr Blood Cancer [J]. Nov,2008,51 (5) : 603-607.
  • 4Ertas G, Ueer A R, Altundag M B, et al. Medulloblastoma/ primitive neuroectodermal tumor in adults:prognostic factors and treatment results: a single-center experience from Turkey[ J]. Med Oncol,2008,25 ( 1 ) :69-72.
  • 5Menon G, Krishnakumar K, Nair S. Adult medulloblastoma: clinical profile and treatment results of 1 8 patients [ J ]. J Clin Neurosci ,2008,15 ( 2 ) : 122-126.
  • 6Lai R. Survival of patients with adult medulloblastoma: a population-based study [ J ]. Cancer,2008,112 ( 7 ) : 1568 -1574.
  • 7Joann L. Ater,Jan van Eys,Shiao Y. Woo,Bartlett Moore III,Donna R. Copeland,Janet Bruner. MOPP chemotherapy without irradiation as primary postsurgical therapy for brain tumors in infants and young children[J] 1997,Journal of Neuro - Oncology(3):243~252
  • 8M. P. Aragonés,R. Magallón,C. Piqueras,L. Ley,J. Vaquero,G. Bravo. Medulloblastoma in adulthood: Prognostic factors influencing survival and recurrence[J] 1994,Acta Neurochirurgica(1-2):65~68

共引文献3

同被引文献15

  • 1许良中,杨文涛.免疫组织化学反应结果的判断标准[J].中国癌症杂志,1996,6(4):229-231. 被引量:1368
  • 2Bai XL,Wu LH,Liang TB. Overexpression of myocyte enhancer factor 2 and histone hyperacetylation in hepatocellular carcinoma[J].{H}Journal of Cancer Research and Clinical Oncology,2008,(01):83-91.
  • 3Nagel S,Meyer C,Quentmeier H. MEF2C is activated by multiple mechanisms in a subset of T acute lymphoblastic leukemia cell lines[J].{H}LEUKEMIA,2008,(03):600-607.
  • 4Faber J,Krivtsov AV,Stubbs MC. HOXA9 is required for survival in human MLL-rearranged acute leukemias[J].{H}Blood,2009,(11):2375-2385.
  • 5Mumcrt M,Dubuc A,Wu X. Functional genomics identifies drivers of medulloblastoma dissemination[J].{H}CANCER RESEARCH,2012,(19):4944-4953.
  • 6Buczkowicz P,Ma J,Hawkins C. GLI2 is a potential therapeutic target in pediatric medulloblastoma[J].J Neuropathpl Exp Neurol,2011,(06):430-437.
  • 7Sturla LM,Cowan CW,Guenther L. A novel role for extracellular signal-regulated kinase5 and myocyte enhancer factor 2in medulloblastoma cell death[J].{H}CANCER RESEARCH,2005,(13):5683-5689.
  • 8Aref D,Moffatt CJ,Agnihotri S. Canonical TGF β pathway activity is a predictor of SHH-Driven medulloblastoma survival and delineates putative precursors in cerebellar development[J].{H}Brain Pathology,2013,(02):178-191.
  • 9Northcott PA,Shih DJ,Peacock J. Subgroup-specific structural variation across 1,000 medulloblastoma genomes[J].{H}NATURE,2012,(7409):49-56.
  • 10Tang X,Yao Y,Zhu J. Differential proliferative index of cancer stem-like cells in primary and recurrent medulloblastoma in human[J].{H}Child's Nervous System,2012,(11):1869-1877.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部